pubmed-article:17073126 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C0242566 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C0016674 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C1707877 | lld:lifeskim |
pubmed-article:17073126 | lifeskim:mentions | umls-concept:C1709269 | lld:lifeskim |
pubmed-article:17073126 | pubmed:dateCreated | 2006-10-31 | lld:pubmed |
pubmed-article:17073126 | pubmed:abstractText | In order to evaluate the incidence and risk factors of infection by hepatitis C virus (HCV) among intravenous drug users we conducted a prospective cohort study of HCV and HIV negative IVDU in the North and East of France. | lld:pubmed |
pubmed-article:17073126 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17073126 | pubmed:language | fre | lld:pubmed |
pubmed-article:17073126 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17073126 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17073126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17073126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17073126 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17073126 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17073126 | pubmed:month | Jul | lld:pubmed |
pubmed-article:17073126 | pubmed:issn | 0398-7620 | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:FilocheBB | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:IlefDD | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:JacobCC | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:DesenclosJ... | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:DecosterAA | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:LucidarmeDD | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:JossePP | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:DelamareCC | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:CyranCC | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:Le StratYY | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:FrémauxDD | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:EmmanuelliJJ | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:BruandetAA | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:HarbonnierJJ | lld:pubmed |
pubmed-article:17073126 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:17073126 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17073126 | pubmed:volume | 54 Spec No 1 | lld:pubmed |
pubmed-article:17073126 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17073126 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17073126 | pubmed:pagination | 1S15-1S22 | lld:pubmed |
pubmed-article:17073126 | pubmed:dateRevised | 2006-12-6 | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:meshHeading | pubmed-meshheading:17073126... | lld:pubmed |
pubmed-article:17073126 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:17073126 | pubmed:articleTitle | [Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France]. | lld:pubmed |
pubmed-article:17073126 | pubmed:affiliation | Institut de Veille Sanitaire, Saint-Maurice. | lld:pubmed |
pubmed-article:17073126 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17073126 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:17073126 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:17073126 | pubmed:publicationType | Evaluation Studies | lld:pubmed |